S

Stoke Therapeutics

D
STOK
USD
0.03
(0.2157%)
Market Closed
43,664.00
حجم التداول
-2.12
الربح لكل سهم
-
العائد الربحي
-6.423963
P/E
733,910,318.06
حجم السوق
اليوم
0.2157%
1 اسبوع
5.089%
1 شهر
9.419%
6 اشهر
8.652%
12 اشهر
197.228%
بداية السنة
164.516%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Stoke Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.
هل تحتاج مساعدة او لديك استفسار؟